RNAi-mediated downregulation of cyclin Y to attenuate human breast cancer cell growth

Yan,Feng; Wang,Xiaoming; Zhu,Mingchen; Hu,Xiaoya

doi:10.3892/or.2016.5126

RNAi-mediated downregulation of cyclin Y to attenuate human breast cancer cell growth

Authors:
- Feng Yan
- Xiaoming Wang
- Mingchen Zhu
- Xiaoya Hu
View Affiliations

Affiliations: College of Chemistry and Chemical Engineering, Yangzhou University, Yangzhou, Jiangsu 225002, P.R. China, Department of Clinical Laboratory, Nanjing Medical University Cancer Hospital and Jiangsu Cancer Hospital, Nanjing, Jiangsu 210009, P.R. China
Published online on: September 23, 2016 https://doi.org/10.3892/or.2016.5126
Pages: 2793-2799

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cyclin Y (CCNY) is a newly identified PFTK1 interacting protein and has been found to be associated with the proliferation and tumorigenesis of human non-small cell lung cancer. In the present study, we analyzed the expression levels of CCNY in 65 cases of breast cancer (BC) tissues and in four BC cell lines, BT-474, MDA-MB-231, T-47D and MCF-7. Lentivirus-mediated short hairpin RNA (shRNA) was employed to knock down CCNY expression in MCF-7 and MDA-MB-231 cells. The effects of CCNY depletion on cell growth were examined by MTT, colony formation and flow cytometry assays. The results showed that immunohistochemical expression of CCNY in tumor tissues is stronger than that in normal tissues. CCNY was also expressed in all four BC cells. The knockdown of CCNY resulted in a significant reduction in cell proliferation and colony formation ability. Cell cycle analysis showed that CCNY knockdown arrested MDA-MB‑231 cells in the G0/G1 phase. Furthermore, depletion of CCNY inhibited BC cell growth via the activation of Bad and GSK3β, as well as cleavages of PARP and caspase-3 in a p53-dependent manner. Therefore, we believe that CCNY has biological effect in BC development, and its inhibition via an RNA interference lentiviral system may provide a therapeutic option for BC.

View Figures

View References

1	Banerji S, Cibulskis K, Rangel-Escareno C, Brown KK, Carter SL, Frederick AM, Lawrence MS, Sivachenko AY, Sougnez C, Zou L, et al: Sequence analysis of mutations and translocations across breast cancer subtypes. Nature. 486:405–409. 2012. View Article : Google Scholar : PubMed/NCBI
2	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
3	Viale G: The current state of breast cancer classification. Ann Oncol. 23(Suppl 10): x207–x210. 2012. View Article : Google Scholar : PubMed/NCBI
4	Nagano T, Hashimoto T, Nakashima A, Hisanaga S, Kikkawa U and Kamada S: Cyclin I is involved in the regulation of cell cycle progression. Cell Cycle. 12:2617–2624. 2013. View Article : Google Scholar : PubMed/NCBI
5	Yue W, Zhao X, Zhang L, Xu S, Liu Z, Ma L, Jia W, Qian Z, Zhang C, Wang Y, et al: Cell cycle protein cyclin Y is associated with human non-small-cell lung cancer proliferation and tumorigenesis. Clin Lung Cancer. 12:43–50. 2011. View Article : Google Scholar : PubMed/NCBI
6	Syed Khaja AS, Dizeyi N, Kopparapu PK, Anagnostaki L, Härkönen P and Persson JL: Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer. PLoS One. 8:e722102013. View Article : Google Scholar : PubMed/NCBI
7	Dai M, Al-Odaini AA, Fils-Aimé N, Villatoro MA, Guo J, Arakelian A, Rabbani SA, Ali S and Lebrun J: Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion. Breast Cancer Res. 15:R492013. View Article : Google Scholar
8	Lamb R, Lehn S, Rogerson L, Clarke RB and Landberg G: Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity. Cell Cycle. 12:2384–2394. 2013. View Article : Google Scholar : PubMed/NCBI
9	Aaltonen K, Amini RM, Landberg G, Eerola H, Aittomäki K, Heikkilä P, Nevanlinna H and Blomqvist C: Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer. Breast Cancer Res Treat. 113:75–82. 2009. View Article : Google Scholar
10	Wei M, Zhu L, Li Y, Chen W, Han B, Wang Z, He J, Yao H, Yang Z, Zhang Q, et al: Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer model. Cancer Sci. 102:1537–1544. 2011. View Article : Google Scholar : PubMed/NCBI
11	Sgambato A, Camerini A, Collecchi P, Graziani C, Bevilacqua G, Capodanno A, Migaldi M, Masciullo V, Scambia G, Rossi G, et al: Cyclin E correlates with manganese superoxide dismutase expression and predicts survival in early breast cancer patients receiving adjuvant epirubicin-based chemotherapy. Cancer Sci. 100:1026–1033. 2009. View Article : Google Scholar : PubMed/NCBI
12	Shaye A, Sahin A, Hao Q, Hunt K, Keyomarsi K and Bedrosian I: Cyclin E deregulation is an early event in the development of breast cancer. Breast Cancer Res Treat. 115:651–659. 2009. View Article : Google Scholar
13	Waltersson MA, Askmalm MS, Nordenskjöld B, Fornander T, Skoog L and Stål O: Altered expression of cyclin E and the retinoblastoma protein influences the effect of adjuvant therapy in breast cancer. Int J Oncol. 34:441–448. 2009.PubMed/NCBI
14	Gao S, Ma JJ and Lu C: Prognostic value of cyclin E expression in breast cancer: A meta-analysis. Tumour Biol. 34:3423–3430. 2013. View Article : Google Scholar : PubMed/NCBI
15	Jiang M, Gao Y, Yang T, Zhu X and Chen J: Cyclin Y, a novel membrane-associated cyclin, interacts with PFTK1. FEBS Lett. 583:2171–2178. 2009. View Article : Google Scholar : PubMed/NCBI
16	Yang T and Chen JY: Identification and cellular localization of human PFTAIRE1. Gene. 267:165–172. 2001. View Article : Google Scholar : PubMed/NCBI
17	Ahlin C, Zhou W, Holmqvist M, Holmberg L, Nilsson C, Jirström K, Blomqvist C, Amini RM and Fjällskog ML: Cyclin A is a proliferative marker with good prognostic value in node-negative breast cancer. Cancer Epidemiol Biomarkers Prev. 18:2501–2506. 2009. View Article : Google Scholar : PubMed/NCBI
18	Xu Y, Wang Z, Wang J, Li J, Wang H and Yue W: Lentivirus-mediated knockdown of cyclin Y (CCNY) inhibits glioma cell proliferation. Oncol Res. 18:359–364. 2010. View Article : Google Scholar : PubMed/NCBI
19	Mikolcevic P, Sigl R, Rauch V, Hess MW, Pfaller K, Barisic M, Pelliniemi LJ, Boesl M and Geley S: Cyclin-dependent kinase 16/PCTAIRE kinase 1 is activated by cyclin Y and is essential for spermatogenesis. Mol Cell Biol. 32:868–879. 2012. View Article : Google Scholar :
20	Mikolcevic P, Rainer J and Geley S: Orphan kinases turn eccentric: A new class of cyclin Y-activated, membrane-targeted CDKs. Cell Cycle. 11:3758–3768. 2012. View Article : Google Scholar : PubMed/NCBI
21	Konishi Y, Lehtinen M, Donovan N and Bonni A: Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. Mol Cell. 9:1005–1016. 2002. View Article : Google Scholar : PubMed/NCBI
22	Cross DA, Alessi DR, Cohen P, Andjelkovich M and Hemmings BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 378:785–789. 1995. View Article : Google Scholar : PubMed/NCBI
23	Jacobs KM, Bhave SR, Ferraro DJ, Jaboin JJ, Hallahan DE and Thotala D: GSK-3β: A bifunctional role in cell death pathways. Int J Cell Biol. 2012:9307102012. View Article : Google Scholar
24	Min HJ, Koh SS, Cho IR, Srisuttee R, Park EH, Jhun BH, Kim YG, Oh S, Kwak JE, Johnston RN, et al: Inhibition of GSK-3β enhances reovirus-induced apoptosis in colon cancer cells. Int J Oncol. 35:617–624. 2009.PubMed/NCBI
25	Bressenot A, Marchal S, Bezdetnaya L, Garrier J, Guillemin F and Plénat F: Assessment of apoptosis by immunohistochemistry to active caspase-3, active caspase-7, or cleaved PARP in monolayer cells and spheroid and subcutaneous xenografts of human carcinoma. J Histochem Cytochem. 57:289–300. 2009. View Article : Google Scholar :